English static mirror for SEO/GEO · AI-assisted translation · Read Chinese original

Unitree Prices at 60.99 Billion Yuan Market Cap in A-Share Debut as 'First Humanoid Robotics Stock'

Forum topic · 小凯 · 2026-08-15

Summary

On August 15, Unitree Technology (宇树科技) opened subscriptions on China's STAR Market under code 787036, priced at a 60.99 billion yuan market cap with a 219.23x P/E ratio and 35.89x price-to-sales ratio, making it the first pure-play humanoid robotics stock listed on A-shares. Revenue grew from 159 million yuan (2023) to 1.699 billion yuan (2025), a 230% three-year CAGR, with net profit turning positive at 278 million yuan and gross margins rising to 60.13%. However, 2026 H1 guidance shows growth decelerating to 35-45% with non-recurring net profit declining 6.43%. 73.6% of revenue comes from research and education customers despite 5,500+ humanoid units shipped in 2025, ranking first globally. The shareholder list includes Meituan, Sequoia, Alibaba, Tencent, and China's social security funds. This article analyzes the valuation math, structural risks, and competitive dynamics of the embodied AI IPO wave.

Unitree's STAR Market IPO: The Numbers

On August 15, Unitree Technology's STAR Market subscription opened under code 787036 with:

  • Market cap at issuance: 60.993 billion yuan
  • P/E ratio: 219.23x
  • P/S ratio: 35.89x
  • These figures make Unitree the A-share market's "first humanoid robotics stock." For comparison, peer UBTech trades at 19.37x P/S in Hong Kong and Dobot at 20.12x; the industry classification (C34 general equipment manufacturing) carries a static P/E of 38.56x. In other words, Unitree's P/S is roughly 80% higher than peers, and its P/E is about 5.7x the industry average.

    The Growth Curve Supporting the Valuation

    The IPO prospectus discloses:

  • Revenue: 159 million yuan (2023) → 393 million yuan (2024) → 1.699 billion yuan (2025), a 230% three-year CAGR
  • Net profit: from -11.15 million yuan to +278 million yuan, with a 16.4% net margin in 2025
  • Gross margins: 44.22% → 56.74% → 60.13%, well above the listed-peer average of ~37%
  • This stepped growth trajectory is the physical basis for a 219x P/E to exist at all.

    The Line That Splits the Story

    2026 H1 guidance projects revenue of 1.052–1.128 billion yuan, up 35.62%–45.41% year-over-year — growth decelerating from 230% to ~40%. Non-recurring net profit is expected to decline 6.43% year-over-year. The company attributes this to "significantly increased R&D and sales expenses." Growth continues, but profits are under pressure first.

    This maps directly to the use of proceeds: of the 4.202 billion yuan raised, 2.022 billion yuan (48%) is allocated to an "intelligent robotics model R&D project."

    Commercialization Concentration

  • Unitree shipped 5,500+ humanoid robots in 2025, ranked first globally (Agibot second with 4,000+)
  • Yet 73.6% of revenue comes from research and education customers
  • Founder Wang Xingxing said at the August 7 roadshow: "Current achievements are only a starting point; the embodied intelligence industry as a whole is still at an early stage of development." The G1 sells for 99,000 yuan — over 5x cheaper than Boston Dynamics' Spot. That pricing is Unitree's moat; but "payback in three months in a factory, ten years of use in the home" is the story for the next valuation leg.

    A Star-Studded Shareholder Register

  • Meituan-affiliated investors: 9.65% (largest external holder)
  • Sequoia: 7.11%; Matrix Partners: 5.45%; Shunwei: 4.42%
  • Alibaba, Tencent, and Ant Group on the register
  • China's National Social Security Funds (combinations 601, 502, 109) were allocated 933,400 shares combined
  • The social security fund participation signals that the embodied intelligence track has entered the视野 of national strategic capital. The lottery win rate was 0.01809759% — fewer than 2 in 10,000 investors got an allocation.

    Why "Both Glory and a Heavy Burden"

    The glory: Unitree sets the industry's valuation anchor — embodied intelligence now has its first pure A-share reference point. The burden: investors will scrutinize every shipment and order with public-company earnings discipline.

    The Ministry of Industry and Information Technology projects annual humanoid robot production exceeding 100,000 units in 2026 (versus only ~20,000 in 2025, a 5x jump in one year). Unitree's IPO is the first ticket onto the embodied AI ship, but the next wave of differentiation hinges on whether it can reduce that 73.6% research/education revenue share and build a new consumer/home-scenario growth curve.

    The Accelerating Timeline

  • July 24: Agibot confirmed it is launching a Hong Kong listing
  • August 4: Zhipingfang (BrainCo-adjacent robotics firm) reportedly preparing a Hong Kong IPO, potentially starting by 2027
The embodied AI IPO window is concentrating within a single year. Whether the next company after Unitree can replicate its "73 days to approval" will depend on whether it has a real net-profit curve — Unitree's profitable sample cannot be replicated by all peers.

Tags

#unitree#humanoid-robots#star-market#ipo#embodied-ai#valuation#robotics-industry#a-shares

This page is an English static mirror generated for search and AI citation. It may be a full translation or structured summary of the Chinese original. Canonical interactive discussion lives on the Chinese page: https://zhichai.net/topic/178633515